Preview Mode Links will not work in preview mode

Mar 22, 2019


Faculty presentations from a CME symposium held at the 2019 Gastrointestinal Cancers Symposium. Featuring perspectives from Drs Andrew E Hendifar, Eileen M O’Reilly, Philip A Philip and Margaret A Tempero:

  • Available and Emerging Research Guiding the Treatment of Resectable or Borderline Resectable Pancreatic Adenocarcinoma (PAD) — Dr Tempero (0:00)
  • Patient- and Disease-Specific Factors Informing the Selection of Therapy for Locally Advanced, Unresectable PAD; Selection of First-Line Treatment for Metastatic Disease — Dr Philip (8:24)
  • Optimal Management of Metastatic Disease After Progression on First-Line Therapy — Dr O’Reilly (17:24)
  • Novel Agents and Strategies Under Investigation — Dr Hendifar (25:21)

Select publications